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Summary: Hedranthera barteri L. (HB) is used in the treatment of painful conditions and oedema amongst its folkloric 
use. The hexane and ethyl acetate fractions of the root of H. barteri were investigated for anti-nociceptive and anti-
inflammatory properties and probable mechanism of action. Hot plate, tail flick, formalin-induced oedema and acetic acid-
induced writhing tests were employed to investigate the anti-nociceptive activity while the anti-inflammatory activity was 
investigated using carrageenan-induced paw oedema. Anti-histaminic potential of HB root extracts on the rat peritoneal 
mast cells (RPMCs) was explored through spectrofluorometric method. The root was screened for its phytochemical 
components. The HB root contains alkaloids, cardenolides and saponins. HXHBR exhibited higher anti-inflammatory 
potentials (P<0.001). HXHBR dose-dependently (P<0.01) reduced the histamine release from the rat peritoneal mast cells 
which is comparable with a standard anti-histaminic drug, ketotifen. These results showed that EAHBR and HXHBR 
possess anti-nociceptive and anti-inflammatory activities, and suggested its mechanism of action through the inhibition of 
histamine, an inflammatory mediator, usually released during the early phase of allergic responses and chronic phase of 
inflammatory pain. Flavonoids, alkaloids and/or saponins present in HB root may be responsible for its anti-nociceptive 
and anti-inflammatory properties. 
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Hedranthera barteri, HB (Family: Apocynaceae) is a 
shrub found in damp situations of the closed forest in 
Ghana, North and South Nigeria, West Cameroon and 
Zaire (Congo Brazzaville). The fruit has been used to 
prevent abortion in women (Thomas, 1910). The leaf 
exudate has been used to treat gonorrhea, as a 
femifuge and to suppress painful tumor (Ainslie, 
1937). The leaf decoction is drunk by Igbo of South 
Nigeria to treat dizziness (Thomas, 1967). The plant 
has been reported to be rich in alkaloids like 
amataine, beninine, goziline, owerreine, subsessiline, 
isoquinoline and vobstusine (William and Li, 1970). 
Studies have shown that its alkaloids have 
antibacterial properties (Ogunlana and Ramstad, 
1975). In a previous in-vitro study aimed at screening 
some Nigerian medicinal plants, HB extract was 
reported to have anti-inflammatory, anti-malarial and 
antibacterial activities (Chukwujekwu et al., 2005) 
while in vivo studies reported its anti-nociceptive and 
anti-inflammatory (Onasanwo and Elegbe, 2006; 
Onasanwo et al., 2008). Beta-sitosterol has been 
suggested to be partly responsible for its anti-
inflammatory pain remedy (Onasanwo et al., 2008). 
 The root extracts of medicinal plants are 
therapeutically active and appear to induce fewer side 
effects than the extracts from the leaves and stems of 
the herb. More than 70 compounds have been 
identified in the roots of natural products including 
diterpinoids, triterpinoids, sesquiterpinoids, alkaloids, 
beta-sitosterol, dulcitol and glycosides (Tao and 
Lipsky, 2000) which are known for their medicinal 
purposes. Most of the active compounds have been 
speculated to be extracted through various solvents 
apart from hexane but recent finding revealed that 
many active anti-inflammatory compounds are 
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present in hexane fractions of many medicinal plants. 
Also, mast cell plays a role in the immune and 
inflammatory responses by sensing a variety of 
pathogenic patterns through cell-surface receptors, 
and contains many granules rich in histamine. 
Histamine is an essential mediator of the 
pathophysiology of many allergic diseases. It has 
been implicated as one of the inflammatory mediators 
released in the first 2-3 hours of inflammatory 
responses.  
 In this study, the anti-nociceptive and anti-
inflammatory activities of hexane and ethyl acetate 
fractions of HB root were investigated and the 
probable mechanism of action, using the assay of 
histamine release was explored. 
 
 
MATERIALS AND METHODS 
 
Plant material and extractions 
 The roots of HB used for this study were 
purchased from the Herbarium Department, Forest 
Research Institute of Nigeria (FRIN), Ibadan, Nigeria 
and authenticated voucher specimen (FHI-108375) 
was deposited there for future reference by Mr. Felix 
Usani. The root of HB was extracted with hexane and 
ethyl acetate by soxhlet extraction yielding 12.4% 
and 16.4% respectively. The solvents were removed 
at 400C under reduced pressure in a rotavapor. The 
semi-solid samples of the extract were stored at 40C 
until when needed. The extracts were prepared as 
suspensions with 2.5% tween 80/normal saline, and 




 The experiments were performed using male 
Sprague Dawley (SD) rats (180±5)g and balb/c mice 
(25±5)g. The animals were kept in standard 
environmental conditions, subjected to a 12 h light–
dark cycle and 25±2 °C relative humidity 50–60%, 
fed with pellets of rodent feed (Ashirwad Industries, 
Chandigarh, India) and water ad libitum. The 
Institutional Animal Care Committee of the Indian 
Institute of Integrative Medicine, Jammu-Tawi, India 
approved the experimental protocols. 
 
Chemicals and Drugs  
 All chemicals/reagents were purchased from 
Sigma Chemical Co. (St. Louis, MO, USA) except 
otherwise stated. Paracetamol, tween 80, glacial 
acetic acid, formaldehyde were purchased from S.D. 
Fine Chemical Pvt. Ltd., Mumbai, India. The 





 The phytochemical screening for alkaloids, 
cardenolides, anthraquinone, saponins, tannins and 
flavonoids was done on the dried root of the plants  
 
Anti-nociceptive activity 
Hot plate test in mice: Pain reflexes in response 
to a thermal stimulus were measured using a hot plate 
apparatus (Ugo Basile, Italy) as described by Eddy 
(1950) with slight modification. The control group of 
mice received normal saline (10ml/kg, p.o.). The test 
group mice were treated with HXHBR and EAHBR 
(25, 100, 200 mg/kg, p.o.) and paracetamol (500 
mg/kg, p.o.). Mice were habituated to the apparatus 
for 1min before the start of the test. They were placed 
on the hot plate of 25.4cm x 25.4cm at (55±1.0)0C, 
which is surrounded by an opened-top acrylic cage 
(19cm tall), with the start/stop button on the timer. A 
30sec cut-off time was used to prevent tissue damage. 
The latency measures were taken both before and 
60min after drug/extract administration, as the time 
elapsed between placing the mice on the hot plate and 
forepaw lick, hind paw flick or jump. Each mouse 
was immediately removed from the hot plate and 
returned to its home cage. 
Tail flick test in rats: The rat tail-flick latency was 
assessed by applying radiant heat on a selected spot 
on the tail, 2.0-2.5cm from the tail tip, using tail flick 
apparatus (Ugo-Basile, Italy) as described by 
D’Amour and Smith (1941). The different test groups 
received various doses of HXHBR and EAHBR (25, 
100, 200mg/kg, p.o.) and paracetamol (500mg/kg, 
p.o.), reference drug, while the control group received 
distilled water (2ml/kg, p.o.). The distal part of the 
tail was placed over a heated nichrome wire and the 
time taken for tail-flick response was recorded both 
before and after drug administration (0, 60, 120 and 
180min). A cut-off time of 20sec was followed to 
avoid undue tissue damage of the tail by the radiant 
heat. 
 
Formalin-induced paw licking test in rats:  
20µL of 2.5% formalin was injected into the plantar 
surface of the left hind-paw of the rat (Hunskar and 
Hole, 1997) 60mins after treatment with the extract. 
The test was carried out in a transparent plastic 
chamber (30 x 30 x 30cm) with a mirror placed at the 
base (bottom) of the chamber to allow an 
unobstructed view of the rats. The time that the rat 
spent licking the injected hind paw was measured as 
an index of pain or nociception. The initial, acute 
nociceptive response (0-5min) after formalin 
injection indicated the first phase while (15-30min) 
indicated the second’s chronic phase. 
 
Acetic acid-induced abdominal writhing test in mice: 
The mice were injected, intraperitoneally, with 
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0.1ml/10g body weight of 3% acetic acid solution one 
hour after treatment with the extract, which induced 
the characteristic writhing (Koster et al., 1959). The 
number of writhing was observed between (5-15min). 
The data were collected and computed according to 
the following formula: 
 
% Inhibition =  
[(Mean no of writhing test) control – (Mean no writhing test) test]   X 100 % 
                     (Mean no of writhing test) control 
 
Anti-inflammatory activity 
Carrageenan-induced paw oedema in rats: Pedal 
inflammation in male albino rats was produced by an 
injection of 0.1ml of 1% carrageenan into the right 
hind foot of the rat under the subplantar aponeurosis 
(Winter et al., 1962). The animals were treated with 
the extract, orally 60min before carrageenan 
injection. The inflammation was quantified by 
measuring the volume displaced by the paw, using a 
plethysmometer (Ugo Basile, Italy) at time 0, 1, 3, 
and 24hrs after carrageenan injection. Ibuprofen 
(100mg/kg) was given as reference drug. The 
inhibiting activity was calculated according to the 
formula: 
 
 % inhibition =     [(Ct – Co) control – (Ct –Co) test]  X 100 
            (Ct –Co) control 
where  Co = Mean paw size in the control group and Ct = 
Mean paw size in the treated group. 
 
Preparation of rat peritoneal mast cells (RPMCs) 
 RPMCs were isolated as described by Kim 
(2000). In brief, rats were anesthetized by ether and 
quickly injected with 20ml of Tyrode buffer B 
(137mM NaCl, 5.3mM glucose, 12mM NaHCO3, 
2.7mM KCl, 0.3mM NaHPO4) containing 0.1% 
gelatin, into the peritoneal cavity and the abdomen 
was gently massaged for about 90sec. The peritoneal 
cavity was carefully opened and the fluid containing 
peritoneal cells was aspirated using a Pasteur pipette. 
Thereafter, the peritoneal cells were sedimented at 
150g for 10min at room temperature and re-
suspended in Tyrode buffer B. Mast cells were 
separated from the major components of rat 
peritoneal cells, i.e. macrophages and small 
lymphocytes (Yurt et al., 1977).  
 
Compound 48/80-induced histamine release 
 Purified RPMCs were re-suspended in Tyrode 
buffer A (10mM HEPES, 130mM NaCl, 5mM KCl, 
1.0mM MgCl2, 1.4 mM CaCl2, 5.6mM glucose, 0.1% 
BSA) and were pre-incubated with HB extracts (25, 
50 and 100µg/ml) for 10 min at 37 °C. The cells were 
further incubated for 20min with compound 48/80 
(100µL). The cells were then incubated for 20min at 
370C before centrifugation at 2000g for 10min.The 
cells were separated from the released histamine. 
400µL of 1N NaOH was added to each tube of the 
cells and stirred constantly on addition of 400µL of 
0.2% O-pthaldehyde in methanol. The tubes were 
allowed to stand for 2min after addition of 200µL of 
3N HCl into the tubes. Then, 3N HCl was added into 
the tubes again.  
 
Assay of histamine release 
Histamine content was measured by the OPA spectro-
fluorometric method according to Shore et al. (1959), 
with excitation and emission wavelengths of 350 and 
450, respectively (slit 2.5nM). The inhibition 
percentage of histamine release was calculated using 
the following equation:  % Inhibition = (A-B)/A x 
100% where A is the histamine released without HB 
and B is the histamine released with HB. 
 
Statistical analysis 
Data are represented as the standard error of the mean 
(S.E.M.) of the different experiments under the same 
conditions. Student’s t-test was used for statistical 
comparison of results. For multiple comparisons, one 
way analysis of variance (ANOVA) was used to 
make a statistical comparison between the groups 
followed by Newman-Keuls Multiple Comparison 






The anti-nociceptive effects of EAHBR on hot plate 
latency assay in mice 
 The anti-nociceptive potential of EAHBR on hot 
plate test using balb/c mice is shown in figure 1. 
EAHBR showed a statistically significant anti-
nociceptive property within the first 1hr with 
200mg/kg at 20.68 ± 1.33sec (P<0.001), 100mg/kg at 
15.56 ± 1.07sec (P<0.01) and 25mg/kg at 13.31 ± 
0.26sec (P<0.05). This revealed a dose-dependent 
manner of its anti-nociceptive property. The 
paracetamol group tolerated pain for 14.12 ± 0.56sec. 
Similar dose-dependent anti-nociceptive property was 
observed at the second hour of the scoring but better 
pronounced with paracetamol (19.04 ± 0.62sec), 
P<0.01, compared with EAHBR at 25, 100 and 
200mg/kg which tolerated pain for 15.32 ± 1.44sec 
(P<0.05), 17.74 ± 0.97sec (P<0.01) and 17.36 ± 
1.31sec (P<0.01) respectively. 25mg/kg of EAHBR 
attained the peak of its activity within three hours 
(18.42 ± 1.44 sec), P<0.01; suggesting its long acting 
property at a lower dose compared with its higher 
dose. The significance of the higher and lower doses 
of the extract at the 1st and 3rd hours respectively, 
were significantly higher compared with the standard 
drug, paracetamol (P<0.001, P<0.01). The effect of 
the EAHBR and paracetamol subsided after the 3rd 
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The anti-nociceptive effects of EAHBR on tail flick 
assay in albino rats 
 The anti-nociceptive properties of various doses 
of EAHBR are shown in figure 2. EAHBR 
(200mg/kg) showed a statistically significant anti-
nociceptive property (6.92 ± 0.59sec), P<0.05, 
together with paracetamol (7.18 ± 1.00 sec), P<0.05; 




Figure 1:   
The anti-nociceptive effects of EAHBR on hot plate latency assay in mice  
Each value is presented as the mean ± S.E.M. (n = 8 mice). *P < 0.05, **P<0.01 or ***P<0.001; significantly different 
from the control value. 
	  
Figure 2:   
The anti-nociceptive effects of EAHBR on tail flick assay in rats. 
Each value is presented as the mean ± S.E.M. (n = 8 rats). *P<0.05; significantly different from the control 
value. 
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The anti-nociceptive effects of HXHBR on tail flick 
assay in albino rats 
 The anti-nociceptive properties of various doses 
of HXHBR are shown in figure 3. HXHBR at 25, 100 
and 200mg/kg showed significant tolerance to pain 
for 11.00 ± 0.84sec (P<0.05), 10.00 ± 0.72sec 
(P<0.05) and 12.00 ± 0.73sec (P<0.01) respectively 
which were comparable to that of paracetamol (11.60 
± 1.00sec), P<0.01. The anti-nociceptive property of 
HXHBR (200mg/kg) was significantly higher than 
that of paracetamol. The anti-nociceptive potential of 
100mg/kg HXHBR reached its peak at the 2nd hour 
after its administration (11 ± 1.30 sec), P<0.01. 
 
The anti-nociceptive effects of EAHBR and HXHBR 
on formalin-induced paw licking in albino rats 
 All the doses of the EAHBR and HXHBR 
showed dose dependent anti-nociceptive properties, 
both at the early and late phases of the paw licking in 
albino rats with the exception of 25mg/kg and 
100mg/kg of EAHBR at the early phase as shown in 
figure 4.  
At the early phase, the licking time for EAHBR (50, 
100 and 200mg/kg) were 28.20 ± 2.80sec, 33.20 ± 
3.97sec and 25.00 ± 3.29sec respectively (P<0.05)  
while for aspirin it was 10.60 ± 0.87sec (P<0.001). At 
the late phase, the licking time of EAHBR (50, 100 
and 200mg/kg) was 144.80 ± 13.36sec (P<0.05), 
102.60 ± 10.27sec (P<0.01) and 59.80 ± 6.28sec 
(P<0.001) respectively while aspirin group was 44.00 
± 1.79sec (P<0.001). 
 At the early phase of the anti-nociceptive 
property of HXHBR in formalin test, the licking time 
for EAHBR (50, 100 and 200mg/kg) were 24.20 ± 
1.80sec (P<0.05), 23.20 ± 3.97sec (P<0.05) and 19.00 
± 1.29sec (P<0.01) respectively while aspirin group is 
10.60 ± 0.87sec (P<0.01). At the late phase, the 
licking time for HXHBR (50, 100 and 200mg/kg) 
was 83.80 ± 5.36sec (P<0.01); 69.60 ± 10.27sec 
(P<0.001) and 63.80 ± 6.280sec (P<0.001) 




The anti-nociceptive effects of EAHBR and HXHBR 
on acetic acid-induced abdominal writhing in mice 
 All doses of EAHBR and HXHBR showed dose 
dependent anti-nociceptive properties in acetic acid-
induced abdominal writhing in mice as shown in 
table 1. The inhibition of the abdominal writhing 
produced by 200mg/kg of EAHBR (68.72%) was 
significantly higher than that of 150mg/kg aspirin 
(66.52%) but 200mg/kg of HXHBR produced an 






Figure 3:   
Anti-nociceptive effects of HXHBR on tail flick assay in albino rats  
Each value is presented as the mean ± S.E.M. (n=8rats). **P<0.01 or ***P<0.001; significantly different from 
the control value. 
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Figure 4:   
Anti-nociceptive effects of EAHBR and HXHBR on formalin-induced paw licking in albino rats in albino rats’ 
Each value is presented as the mean ± S.E.M. (n = 8 rats). *P<0.05, **P<0.01 or ***P<0.001; significantly 
different from the control value. 
 
Table 1:  
The effects of EAHBR and HXHBR on acetic acid-induced abdominal writhing in mice.  
Treatment/  EAHBR HXHBR 
Dose(mg/kg) Number of writhing % Inhibition Number of writhing % Inhibition 
Normal Saline  45.4 ± 1.50 0 59.4 ± 1.47 0 
25 24.2 ± 1.42** 46.7 24.6 ± 2.24 58.59 
100 21.8 ± 1.77*** 51.98 21.4 ± 1.28*** 63.97 
200 14.2 ± 0.96*** 68.72 16.6 ± 1.07*** 72.05 
Aspirin (150) 15.2 ± 1.39*** 66.52 13.0 ± 1.18*** 78.12 
Values are expressed as mean ± S.E.M. (n = 8mice). **P<0.01, ***P<0.001; significantly different from the control value.  
 
	  
Figure 5:   
Effects of HXHBR and EAHBR on carrageenan-induced paw oedema in albino rats. 
Values are expressed as mean ± S.E.M. (n = 8 rats), *P < 0.05, **P < 0.01, ***P < 0.001; significantly different from the 
control value. 
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Figure 6:  
Effect of HXHBR and EAHBR on compound 48/80-induced histamine release from the rat peritoneal mast cells of albino 
rats.  Each value is expressed as mean ± S.E.M. of six independent experiments. *P < 0.05 or **P < 0.01; significantly 
different from the control value. 
 
Anti-inflammatory effects of HXHBR and EAHBR on 
carrageenan-induced paw oedema in albino rats 
 The effects of HXHBR and EAHBR on 
carrageenan-induced paw oedema in albino rats are 
shown in figure 5. HXHBR (200mg/kg) showed anti-
oedematous effect of 29.9%, 36.5% and 38.8% at the 
3rd, 4th and 24th hours respectively when compared 
with the zero hour paw volume after carrageenan 
administration. But EAHBR showed no significant 
anti-inflammatory potential. The reference 
compound, Ibuprofen (100mg/kg) showed anti-
oedematous effect of 47.1%, 82.8% , 80.4% and 
69.6% at the 1st , 2nd , 3rd and 4th hours respectively 
when compared with the zero hour paw volume after 
carrageenan administration. The anti-oedematous 
effect induced by ibuprofen reached the peak effect at 
the 2nd hour and progressively decreased. 
 
Effect of HXHBR and EAHBR on compound 48/80-
induced histamine release from the rat peritoneal 
mast cells (RPMCs) of albino rats  
 The inhibitory effects of HXHBR and EAHBR 
on compound 48/80-induced histamine released from 
RPMCs of albino rats are shown in figure 6. HXHBR 
and EAHBR dose-dependently inhibited compound 
48/80-induced histamine release. HXHBR (50 and 
100µg/ml) showed a significant inhibition rate in 
histamine release with 100µg/ml HXHBR inhibition 
of 59.6% (P < 0.01) compared to 74.8% histamine 
inhibition by 10µg/ml ketotifen (P < 0.01). EAHBR 




 In our previous study, the leave extracts of 
Hedranthera barteri (HB) and their fractions have 
been reported to possess anti-inflammatory and anti-
nociceptive properties (Onasanwo and Elegbe, 2006; 
Onasanwo et al., 2008) but in this piece of research 
work, the hexane (HXHBR) and ethyl acetate 
(EAHBR) fractions of HB root were explored for 
their anti-inflammatory and anti-nociceptive 
properties. The earlier study suggested the 
involvement of β-sitosterol in the anti-inflammatory 
property of the HB leaf (Onasanwo et al., 2008) and 
we decided to use the hexane-extracted fraction of the 
root (basically of fatty compounds) and the ethyl 
acetate-extracted fraction for the analgesic and anti-
inflammatory studies of the root. The present study 
revealed that the HXHBR and EAHBR have 
protections against nociception and inflammation 
through thermally and chemically-induced models 
and the HXHBR presented better significant anti-
histaminic property. 
 In the hot plate latency assay, only EAHBR 
showed anti-nociceptive property (figure 1) and no 
significant protection was observed in HXHBR 
(results not shown). Hot plate assay represent the 
thermal model for inducing peripheral pain. The trend 
of the anti-nociceptive effect of EAHBR revealed its 
dose-dependent manner and observations from these 
suggested that the lower dose of EAHBR (25mg/kg) 
has a long duration acting potential while the high 
dose (200mg/kg) has a short duration action.  
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 The tail flick test involves the central nervous 
system and the HXHBR may have its action mediated 
through the central nervous system more than the 
peripheral level when compared with the EAHBR 
(figures 2 and 3). The significant protection of 
HXHBR (200mg/kg) after 60 min of exposure to 
thermal ray was comparable with paracetamol (figure 
3). The significant effects of HXHBR and EAHBR 
extracts on tail flick response of the rats to 
nociception suggest its central effect since the tail 
flick assay is of a spinal reflex, and is considered to 
be selective for centrally acting analgesic compounds 
(Ramabadran et al., 1989; Srinivasan et al., 2003) 
 Intraplantar injection of formalin into the rat hind 
paw produces a biphasic pain response that consists 
of an early, acute phase and a late, tonic phase that is 
manifested behaviorally as flinching and licking of 
the affected paw. The two phases represented the 
direct effect on nociceptors and inflammatory 
nociceptive responses, respectively (Hunskaar and 
Hole, 1997; Rosland et al., 1990; Tjolsen et al., 
1992). Formalin-induced paw licking in albino rats 
represent a chemically-induced burning pain. Both 
the EAHBR and HXHBR extracts showed a dose 
dependent manner of anti-inflammatory potentials 
which were comparable with aspirin (standard drug). 
 Acetic acid-induced abdominal writhing 
represents the very sensitive model for screening 
compounds with anti-nociceptive potentials. The 
writhing activity consists of a contraction of the 
abdominal muscles together with a stretching of the 
hind limbs which is considered to be nociceptive 
(Hern´andez-P´erez and Rabanal, 2002). They 
suggested that where a substance or compound has a 
long latency, as observed with acetic acid, it might 
have acted indirectly, possibly by liberating an 
endogenous substance that excites pain endings. 
Many of the endogenous substances that elicit this 
response have been shown to induce nociceptive 
responses in the dog (Guzman et al., 1962), guinea-
pig (Collier and Lee, 1963), and rat (Deffenu et al., 
1966; Blane, 1967). Both extracts showed dose 
dependent activities while the 200mg/kg of EAHBR 
showed a significantly higher anti-nociceptive 
property (P<0.001) than aspirin (table 1).  
 In the carrageenan-induced paw oedema model of 
inflammation in rat, anti-inflammatory activity of 
HXHBR was significantly higher with all the doses, 
when compared with EAHBR. Only 200mg/kg of 
HXHBR showed significant protection at the 3rd and 
4th hours while EAHBR extract produced no 
significant inhibition. Ibuprofen, a known analgesic 
and anti-inflammatory drug, produced a significant 
anti-inflammatory potential, as much as 82.8% within 
the first 2 hours and almost double (69.5%) the anti-
inflammatory potential of the HXHBR extract 
(36.5%) within 4 hours after carrageenan injection. 
Indeed, carrageenan has been used mostly to study 
anti-inflammatory effect of  both P<0.001 steroidal 
and non-steroidal anti-inflammatory drugs because of 
inflammatory mediators involved both at the initial 
and late phases (Al-Rehaily et al., 2001). Vascular 
permeability of histamine, serotonin and bradykinin 
has been implicated at the initial phase (Vinger et al., 
1987).  
 Histamine, a biogenic amine, amongst other 
mediators, plays a very vital role at the early phase of 
allergic responses and inflammation. Both the 
HXHBR and EAHBR showed antihistaminic 
potentials in a dose dependent manner with more 
significant inhibition in hexane extract, depicting the 
presence of more potent anti-inflammatory metabolite 
or compound in HXHBR. This corroborates the 
reports of some researchers whose findings have 
shown hexane extracts of natural products to possess 
analgesic and anti-inflammatory properties (Alcaraz 
et al., 1989; Garcı´a et al., 1999; Dongmo et al., 
2001; Jorge et al., 2004; Delporte et al., 2005). 
Although, the EAHBR extract showed no significant 
inhibition, in-vivo, in carrageenan-induced paw 
oedema, but the sensitivity of the in-vitro assay 
compared to the in-vivo experiment was observed. 
Since the β-sitosterol has been suggested as likely 
compound with anti-inflammatory properties present 
in HB leaf extract (Onasanwo et al., 2008), further 
chromatographic analysis of the HB root extract will 
be needed for its probable presence in the root. Also, 
compound 48/80 has been implicated in the 
conductance of chloride ion channel and increase in 
the permeability of the lipid bi-layer membrane, 
causing a threat to membrane integrity (Tasaka et al., 
1986; Lau and Wan, 2000) in the process of mast cell 
degranulation. The potentials of HXHBR extracts in 
inhibiting these membrane threats by compound 
48/80 may not be ruled out. Studies are needed in this 
direction to elucidate these claims. 
 The phytochemical screening of the root sample 
of Hedranthera barteri has revealed the presence of 
alkaloids, cardenolides, saponins and flavonoids. 
Medicinal plants with flavonoids and saponins 
(Calixto et al., 2000; Guardia et al., 2001; Rotelli et 
al., 2003) have been reported to possess analgesic 
and anti-inflammatory properties. The anti-
nociceptive and anti-inflammatory effects observed in 
the present work may be due to the presence of these 
compounds, though the chromatographic separation 
of these compounds is needed to ascertain this 
speculation. 
 Conclusively, these results showed that hexane 
(HXHBR) and ethyl acetate (EAHBR) extracts of the 
HB root possess anti-nociceptive and anti-
inflammatory activities. It is suggested that its 
mechanism of action may be through the inhibition of 
histamine, an inflammatory mediator, usually 
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released during the early phase of allergic responses 
and chronic phase of inflammatory pain amongst 
some other factors. Flavonoids and saponins present 
in HB root may be involved in its anti-nociceptive 
and anti-inflammatory properties. 
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